Join us for a presentation about a treatment for hereditary ATTR (hATTR) amyloidosis Alnylam PHARMACEUTICALS ABOUT THE PROGRAM You are invited to join us to learn more about a treatment for the polyneuropathy of hATTR amyloidosis in adults. There is no cost to attend this event. Dinner and refreshments will be provided THIS PROGRAM FEATURED PROGRAM WILL COVER: Who Ainylam Patient Education Liaison, Peg Palozi, joined by Ambassador, Gary, a patient living with hATTR amyloidosis Disease Overview and J.David Avilsa, MD Clinical Assistant Professor Geisinger Commonwealth School of Medicine Danville, PA Information About a Treatment Option Where: LaCucina 600 South Blakley Sreet Dunmore, PA 18510 Resources and Support When: Wednesday, August 28, 2019 6:00 PM ET REGISTER NOW! hattrpatientevents.com/2657-133 OR CALL 1-877-871-0967 This program is intended for people interested in learning about hATTR amyloidosis, including individuals diagnosed with hATTR amyloidosis, their familes, and caregivers TTR02-USA-00154 2019 Alnylam Pharmaceuticals, Inc. All rights reserved Join us for a presentation about a treatment for hereditary ATTR (hATTR) amyloidosis Alnylam PHARMACEUTICALS ABOUT THE PROGRAM You are invited to join us to learn more about a treatment for the polyneuropathy of hATTR amyloidosis in adults. There is no cost to attend this event. Dinner and refreshments will be provided THIS PROGRAM FEATURED PROGRAM WILL COVER: Who Ainylam Patient Education Liaison, Peg Palozi, joined by Ambassador, Gary, a patient living with hATTR amyloidosis Disease Overview and J.David Avilsa, MD Clinical Assistant Professor Geisinger Commonwealth School of Medicine Danville, PA Information About a Treatment Option Where: LaCucina 600 South Blakley Sreet Dunmore, PA 18510 Resources and Support When: Wednesday, August 28, 2019 6:00 PM ET REGISTER NOW! hattrpatientevents.com/2657-133 OR CALL 1-877-871-0967 This program is intended for people interested in learning about hATTR amyloidosis, including individuals diagnosed with hATTR amyloidosis, their familes, and caregivers TTR02-USA-00154 2019 Alnylam Pharmaceuticals, Inc. All rights reserved